Ovid Therapeutics Inc. Increase (Decrease) in Other Noncurrent Assets
Ovid Therapeutics Inc. (OVID) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2024-11-12
- Ovid Therapeutics Inc. increase (decrease) in other noncurrent assets for the quarter ending 2024-09-30 was $0.00.
- Ovid Therapeutics Inc. increase (decrease) in other noncurrent assets for the quarter ending 2024-06-30 was $0.00.
- Ovid Therapeutics Inc. increase (decrease) in other noncurrent assets for the quarter ending 2024-03-31 was $0.00.
- Ovid Therapeutics Inc. increase (decrease) in other noncurrent assets for the quarter ending 2023-09-30 was $0.00.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed |
|---|---|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | |||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | -$12.00K 10-Q · filed 2024-11-12 | -$12.49K 10-Q · filed 2023-11-03 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$12.00K 10-Q · filed 2024-08-13 | -$12.49K 10-Q · filed 2023-08-04 | |||
| 2023-03-31 | -$12.00K 10-Q · filed 2024-05-14 | -$12.49K 10-Q · filed 2023-05-05 | ||||
| 2022-09-30 | -$41.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$61.25K derived: sum of 2 quarters · filed 2023-11-03 | -$56.94K 10-Q · filed 2023-11-03 | |||
| 2022-06-30 | -$20.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$15.92K 10-Q · filed 2023-08-04 | ||||
| 2022-03-31 | $4.30K 10-Q · filed 2023-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |